You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

moderate cGVHD

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH

Recruiting
  • Chronic Graft-versus-Host-Disease
  • +4 more
    • San Francisco, California
    • +15 more
    Jun 17, 2022

    Chronic GVHD, Steroid Refractory GVHD Trial in Duarte (Leflunomide)

    Recruiting
    • Chronic Graft Versus Host Disease
    • Steroid Refractory Graft Versus Host Disease
    • Duarte, California
      City of Hope Medical Center
    Sep 14, 2022

    Graft-versus-host Disease (GVHD) Trial (Ruxolitinib)

    Approved for marketing
    • Graft-versus-host Disease (GVHD)
    • (no location specified)
    Jan 26, 2023

    Pediatric cGVHD Symptom Scale

    Recruiting
    • Graft vs Host Disease
      • Aurora, Colorado
      • +11 more
      Jan 27, 2023

      CMV Infection, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Letermovir Pill)

      Recruiting
      • CMV Infection
      • Hematopoietic Stem Cell Transplantation
      • Letermovir Pill
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Aug 26, 2023

      Steroid-refractory Acute Graft-versus-host Disease Trial in Worldwide (MC0518, BAT)

      Recruiting
      • Steroid-refractory Acute Graft-versus-host Disease
      • MC0518
      • BAT
      • Amiens, France
      • +37 more
      Nov 1, 2022

      Refractory Leukemia Trial in Shanghai (CALGE-VEN- RIC-MBF)

      Recruiting
      • Refractory Leukemia
      • CALGE-VEN- RIC-MBF
      • Shanghai, Shanghai, China
      • +2 more
      May 22, 2023

      Patients at Risk for Chronic Graft-Versus-Host Disease

      Not yet recruiting
      • cGVHD
      • Non-Interventional
      • (no location specified)
      Jun 16, 2023

      Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)

      Completed
      Has Results
      • Leukemia
      • Lymphoma
      • Total Lymphoid Irradiation
      • +10 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      Oct 28, 2022

      Chronic GVHD Trial in Duarte (biological, procedure, other)

      Active, not recruiting
      • Chronic Graft Versus Host Disease
      • Aldesleukin
      • +3 more
      • Duarte, California
        City of Hope Medical Center
      Jan 4, 2023

      Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

      Not yet recruiting
      • Acute Leukemia
      • +4 more
      • (no location specified)
      Oct 18, 2022

      Hematologic Malignancies Trial in Worldwide (Itacitinib, Calcineurin inhibitor)

      Terminated
      • Hematologic Malignancies
      • Aurora, Colorado
      • +16 more
      Apr 29, 2022

      Microbiota Composition With cGVHD After Allo-HSCT

      Recruiting
      • Hematopoietic Stem Cell Transplantation
      • +3 more
      • blood sample
      • stool sample
      • Hangzhou, Zhejiang, China
      • +9 more
      Jul 31, 2022

      Chronic Graft Vs. Host Disease Trial (INCA34176)

      Available
      • Chronic Graft Vs. Host Disease
      • (no location specified)
      Sep 14, 2022

      Specific Treatments in Patients With cGVHD, PQRST Study

      Recruiting
      • Chronic Graft Versus Host Disease
      • Biospecimen Collection
      • +3 more
      • Tampa, Florida
      • +7 more
      Aug 16, 2022

      Allogenic Stem Cell Transplantation Trial (SAR445419)

      Not yet recruiting
      • Allogenic Stem Cell Transplantation
      • (no location specified)
      Feb 13, 2023

      Bronchiolitis Obliterans, Graft Vs Host Disease Trial in Palo Alto (Pirfenidone 267 MG [Esbriet])

      Completed
      • Bronchiolitis Obliterans
      • Graft Vs Host Disease
      • Pirfenidone 267 MG [Esbriet]
      • Palo Alto, California
        Stanford University School of Medicine
      Jun 8, 2022

      Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

      Not yet recruiting
      • Acute Leukemia
      • +4 more
      • Haploidentical hematopoietic cell transplantation (haploHCT)
      • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
      • (no location specified)
      Jul 13, 2022

      Acute Myeloid Leukemia Trial in Worldwide (Sabatolimab, Azacitidine)

      Recruiting
      • Acute Myeloid Leukemia
      • Marseille, France
      • +11 more
      Mar 29, 2022

      Bronchiolitis Obliterans Syndrome, Hematologic Malignancy Trial in Hangzhou (Ruxolitinib)

      Recruiting
      • Bronchiolitis Obliterans Syndrome
      • Hematologic Malignancy
      • Hangzhou, Zhejiang, China
        The first Affiliated Hospital of Zhejiang University
      Oct 18, 2022

      The Optimization of Haploidentical Hematopoietic Stem Cell

      Not yet recruiting
      • Hematological Malignancy
      • ATG
      • Post-transplantation cyclophosphamide
      • Beijing, Beijing, China
        People's Hospital of Peking University
      Nov 28, 2022

      Chronic Graft-versus-host-disease Trial in United States (SNDX-6352)

      Active, not recruiting
      • Chronic Graft-versus-host-disease
      • Birmingham, Alabama
      • +10 more
      Aug 18, 2022

      Chronic GVHD Trial in Hanzhou (TQ05105 Tablet)

      Unknown status
      • Chronic Graft Versus Host Disease
      • TQ05105 Tablet
      • Hanzhou, Zhejiang, China
        The First Affiliated Hospital, Zhejiang University School of Med
      Jun 26, 2021

      Cytomegalovirus Infection After HSCT and PT-CY as GVHD

      Completed
      • CMV Infection
        • Malaga, Spain
          Maria Jesus Pascual
        Mar 30, 2022

        Chronic Graft-versus-host-disease Trial in Salt Lake City (Itacitinib, Extracorporeal Photopheresis (ECP))

        Active, not recruiting
        • Chronic Graft-versus-host-disease
        • Salt Lake City, Utah
          Huntsman Cancer Institute at University of Utah
        Jan 30, 2023